Rebecca Whitney Named CEO of Young Innovations
Rebecca Whitney took the helm as Chief Executive Officer of Young Innovations on July 1, 2026, assuming responsibility for the global dental manufacturer’s strategic direction and operations. She transitions to the role following a tenure as CEO of Highridge Medical, bringing over two decades of medical technology leadership to the organization.
Whitney’s career spans extensive executive experience within the spine and orthopedics sectors, including senior roles at GE Healthcare, Covidien, and Zimmer Biomet. Chairman of the Board David Butler cited her history of scaling organizations and integrating acquisitions as primary drivers for the appointment, noting her specific expertise in collaborating with clinicians to bring new technologies to market.
At Young Innovations, Whitney will oversee a diverse portfolio of dental brands. Her background emphasizes both organic growth and expansion through acquisition, as well as navigating complex distribution channels. A graduate of the University of Utah with an MBA, she will operate from Denver as she looks to build on the company’s current market momentum.
Comments (0)
No comments yet. Be the first!